Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Accolade Inc ACCD

Healthcare Medical Care
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion... see more

Recent & Breaking News (NDAQ:ACCD)

Accolade to Announce Fiscal Third Quarter 2025 Financial Results

GlobeNewswire 8 days ago

Accolade To Present at Upcoming Investor Conferences

GlobeNewswire November 13, 2024

Accolade Welcomes Renalogic to Trusted Partner Ecosystem

PR Newswire October 15, 2024

Accolade Announces Results for Fiscal Second Quarter 2025

GlobeNewswire October 8, 2024

Accolade to Announce Fiscal Second Quarter 2025 Financial Results

GlobeNewswire September 18, 2024

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Accolade, Inc. (ACCD)

Accesswire August 29, 2024

Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference

GlobeNewswire August 28, 2024

Accolade, Inc. (ACCD) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates

Accesswire August 28, 2024

Accolade, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ACCD

Accesswire August 27, 2024

Accolade, Inc. (ACCD) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

Accesswire August 26, 2024

Accolade Being Investigated on Behalf of Accolade, Inc. Investors. Contact Levi & Korsinsky For Details.

Accesswire August 23, 2024

First-of-its-kind Healthcare Innovation Provides Synchronized, Customized Whole-Health Strategies

PR Newswire August 22, 2024

Shareholder Rights Advocates at Levi & Korsinsky Investigate Accolade, Inc. (ACCD) Regarding Possible Securities Fraud Violations

Accesswire August 22, 2024

Lost Money on Accolade, Inc.(ACCD)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

Accesswire August 21, 2024

Did Accolade, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - ACCD

Accesswire August 16, 2024

Lost Money on Accolade, Inc.(ACCD)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky

Accesswire August 15, 2024

Shareholder Rights Advocates at Levi & Korsinsky Investigate Accolade, Inc. (ACCD) Regarding Possible Securities Fraud Violations

Accesswire August 14, 2024

Accolade, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Accolade (ACCD)

Accesswire August 13, 2024

ACCD STOCK ALERT: Levi & Korsinsky Notifies Accolade, Inc. Investors of an Ongoing Investigation

Accesswire August 12, 2024

ATTENTION ACCD SHAREHOLDERS: Investors who lost money on Accolade, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

Accesswire August 9, 2024